HomeGNTA • NASDAQ
Genenta Science SPA
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.62M | 6.35% |
Net income | -2.44M | 0.25% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.61M | -6.35% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.66M | -32.57% |
Total assets | 14.82M | -33.66% |
Total liabilities | 2.33M | 21.59% |
Total equity | 12.50M | — |
Shares outstanding | 18.29M | — |
Price to book | 5.13 | — |
Return on assets | -44.24% | — |
Return on capital | -52.42% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.44M | 0.25% |
Cash from operations | -2.09M | -15.37% |
Cash from investing | 1.29M | 152.81% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -803.11K | 81.15% |
Free cash flow | -1.40M | -2.15% |
Previous close
$3.49
Day range
$3.36 - $3.69
Year range
$2.20 - $7.28
Market cap
63.65M USD
Avg Volume
34.81K
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
13
